Roman DBDR Acquisition (DRDB) Liabilities and Shareholders Equity (2024 - 2026)
Roman DBDR Acquisition (DRDB) posted Liabilities and Shareholders Equity of $243.1 million for Q1 2026, up 0.64% sequentially from $241.5 million in Q4 2025, and up 3.44% YoY from $235.0 million in Q1 2025.
Roman DBDR Acquisition (DRDB) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
Roman DBDR Acquisition has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $243.1 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 3.44% year-over-year to $243.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $960.9 million (changed N/A YoY) and the FY2025 annual result came in at $241.5 million, up 19.08% from the prior year.
- Liabilities and Shareholders Equity rose to $243.1 million in Q1 2026 per DRDB's latest filing, from $241.5 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $243.1 million in Q1 2026 and troughed at $202.8 million in Q4 2024.
- A 3-year average of $233.1 million and a median of $238.2 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity grew 19.08% in 2025, then increased 3.44% in 2026.
- Over 3 years, Liabilities and Shareholders Equity stood at $202.8 million in 2024, then rose by 19.08% to $241.5 million in 2025, then grew by 0.64% to $243.1 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $243.1 million, $241.5 million, and $239.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 261.48 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 245.80 Mn |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 514.10 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 464.99 Mn |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 98.35 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 247.73 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 314.37 Mn |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 374.60 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 376.80 Mn |
| 10 | Roman DBDR Acquisition | 244.72 Mn | 244.72 Mn | - | 245.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 245.65 Mn |
| Mar 31, 2026 | 243.06 Mn |
| Dec 31, 2025 | 241.51 Mn |
| Sep 30, 2025 | 239.33 Mn |
| Jun 30, 2025 | 237.01 Mn |
| Mar 31, 2025 | 234.96 Mn |
| Dec 31, 2024 | 202.81 Mn |